Global Personalized Medicine Market Growth (Status and Outlook) 2019-2024
Table of Contents
2019-2024 Global Personalized Medicine Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Personalized Medicine Market Size 2014-2024
- 2.1.2 Personalized Medicine Market Size CAGR by Region
- 2.2 Personalized Medicine Segment by Type
- 2.2.1 Personalized Medicine Diagnostics
- 2.2.2 Personalized Medical Care
- 2.2.3 Personalized Medicine Therapeutics
- 2.2.4 Personalized Nutrition and Wellness
- 2.3 Personalized Medicine Market Size by Type
- 2.3.1 Global Personalized Medicine Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Personalized Medicine Market Size Growth Rate by Type (2014-2019)
- 2.4 Personalized Medicine Segment by Application
- 2.4.1 Oncology
- 2.4.2 Central Nervous System (CNS)
- 2.4.3 Immunology
- 2.4.4 Respiratory
- 2.4.5 Other Applications
- 2.5 Personalized Medicine Market Size by Application
- 2.5.1 Global Personalized Medicine Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Personalized Medicine Market Size Growth Rate by Application (2014-2019)
3 Global Personalized Medicine by Players
- 3.1 Global Personalized Medicine Market Size Market Share by Players
- 3.1.1 Global Personalized Medicine Market Size by Players (2017-2019)
- 3.1.2 Global Personalized Medicine Market Size Market Share by Players (2017-2019)
- 3.2 Global Personalized Medicine Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Personalized Medicine by Regions
- 4.1 Personalized Medicine Market Size by Regions
- 4.2 Americas Personalized Medicine Market Size Growth
- 4.3 APAC Personalized Medicine Market Size Growth
- 4.4 Europe Personalized Medicine Market Size Growth
- 4.5 Middle East & Africa Personalized Medicine Market Size Growth
5 Americas
- 5.1 Americas Personalized Medicine Market Size by Countries
- 5.2 Americas Personalized Medicine Market Size by Type
- 5.3 Americas Personalized Medicine Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Personalized Medicine Market Size by Countries
- 6.2 APAC Personalized Medicine Market Size by Type
- 6.3 APAC Personalized Medicine Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Personalized Medicine by Countries
- 7.2 Europe Personalized Medicine Market Size by Type
- 7.3 Europe Personalized Medicine Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Personalized Medicine by Countries
- 8.2 Middle East & Africa Personalized Medicine Market Size by Type
- 8.3 Middle East & Africa Personalized Medicine Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Personalized Medicine Market Forecast
- 10.1 Global Personalized Medicine Market Size Forecast (2019-2024)
- 10.2 Global Personalized Medicine Forecast by Regions
- 10.2.1 Global Personalized Medicine Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Personalized Medicine Forecast by Type
- 10.8 Global Personalized Medicine Forecast by Application
11 Key Players Analysis
- 11.1 Abbott Laboratories
- 11.1.1 Company Details
- 11.1.2 Personalized Medicine Product Offered
- 11.1.3 Abbott Laboratories Personalized Medicine Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Abbott Laboratories News
- 11.2 Agilent Technologies
- 11.2.1 Company Details
- 11.2.2 Personalized Medicine Product Offered
- 11.2.3 Agilent Technologies Personalized Medicine Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Agilent Technologies News
- 11.3 Amgen
- 11.3.1 Company Details
- 11.3.2 Personalized Medicine Product Offered
- 11.3.3 Amgen Personalized Medicine Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Amgen News
- 11.4 Astellas Pharma
- 11.4.1 Company Details
- 11.4.2 Personalized Medicine Product Offered
- 11.4.3 Astellas Pharma Personalized Medicine Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Astellas Pharma News
- 11.5 Astrazeneca
- 11.5.1 Company Details
- 11.5.2 Personalized Medicine Product Offered
- 11.5.3 Astrazeneca Personalized Medicine Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Astrazeneca News
- 11.6 Bayer AG
- 11.6.1 Company Details
- 11.6.2 Personalized Medicine Product Offered
- 11.6.3 Bayer AG Personalized Medicine Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Bayer AG News
- 11.7 Celgene Corporation
- 11.7.1 Company Details
- 11.7.2 Personalized Medicine Product Offered
- 11.7.3 Celgene Corporation Personalized Medicine Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Celgene Corporation News
- 11.8 Glaxosmithkline Plc
- 11.8.1 Company Details
- 11.8.2 Personalized Medicine Product Offered
- 11.8.3 Glaxosmithkline Plc Personalized Medicine Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Glaxosmithkline Plc News
- 11.9 Illumina
- 11.9.1 Company Details
- 11.9.2 Personalized Medicine Product Offered
- 11.9.3 Illumina Personalized Medicine Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Illumina News
- 11.10 Johnson & Johnson
- 11.10.1 Company Details
- 11.10.2 Personalized Medicine Product Offered
- 11.10.3 Johnson & Johnson Personalized Medicine Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Johnson & Johnson News
- 11.11 Laboratory Corporation
- 11.12 Merck
- 11.13 Novartis AG
- 11.14 Roche Holding AG
- 11.15 Siemens AG
- 11.16 Takeda Pharmaceutical Company Limited
12 Research Findings and Conclusion
Individualized medication, medication "vary from person to person" , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.
According to this study, over the next five years the Personalized Medicine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Personalized Medicine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Personalized Medicine market by product type, application, key companies and key regions.
This study considers the Personalized Medicine value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Personalized Medicine Diagnostics
Personalized Medical Care
Personalized Nutrition and Wellness
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Oncology
Central Nervous System (CNS)
Immunology
Respiratory
Other Applications
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Agilent Technologies
Amgen
Astellas Pharma
Astrazeneca
Bayer AG
Celgene Corporation
Glaxosmithkline Plc
Illumina
Johnson & Johnson
Laboratory Corporation
Merck
Novartis AG
Roche Holding AG
Siemens AG
Takeda Pharmaceutical Company Limited
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Personalized Medicine market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Personalized Medicine market by identifying its various subsegments.
Focuses on the key global Personalized Medicine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Personalized Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Personalized Medicine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.